Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization

Arthritis and Rheumatism

Volumn 43, Issue 7, 2000, Pages 1560-1570

  Johnson, Kristen ^a   Jung, Alexander ^a   Murphy, Anne ^b   Andreyev, Alexander ^b   Dykens, James ^b   Terkeltaub, Robert ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Migenix Inc   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIMYCIN A1; CALCIUM 45; COLLAGEN; DNA; GLYCOPROTEIN; HYDROXYAPATITE; LACTATE DEHYDROGENASE; LACTIC ACID; NITRIC OXIDE; OLIGOMYCIN; PEROXYNITRITE; PROTEOGLYCAN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; PYROPHOSPHATE; TRANSFORMING GROWTH FACTOR BETA; UBIQUINOL CYTOCHROME C REDUCTASE;

ARTICLE; CALCIFICATION; CARTILAGE CELL; CELL IMMORTALIZATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ELECTRON TRANSPORT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MINERALIZATION; MITOCHONDRIAL RESPIRATION; OSTEOARTHRITIS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS;

ADENOSINE TRIPHOSPHATE; ANTIMYCIN A; CALCIFICATION, PHYSIOLOGIC; CARTILAGE, ARTICULAR; CELL LINE, TRANSFORMED; CELL SURVIVAL; CHONDROCYTES; DIPHOSPHATES; EXTRACELLULAR MATRIX; HUMANS; MITOCHONDRIA; NITRIC OXIDE; OLIGOMYCINS; OXIDATIVE PHOSPHORYLATION; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033939459     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.0.CO;2-S     Document Type: Article

References (53)

1. Pelletier J, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, et al. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor. Osteoarthritis Cartilage 1999;7:416-8.
2. Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998;41:1266-74.
3. Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD, Evans CH. Nitric oxide in osteoarthritis. Osteoarthritis Cartilage 1999;7: 377-9.
4. Lotz M. The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 1999;25:269-82.
5. Frenkel SR, Clancy RM, Ricci JL, Di Cesare PE, Rediske JJ, Abramson SB. Effects of nitric oxide on chondrocyte migration, adhesion, and cytoskeletal assembly. Arthritis Rheum 1996;39: 1905-12.
6. Clancy RM, Rediske J, Tang X, Nijher N, Frenkel S, Philips M, et al. Outside-in signaling in the chondrocyte: nitric oxide disrupts fibronectin-induced assembly of a subplasmalemmal actin/rho A/focal adhesion kinase signaling complex. J Clin Invest 1997;100: 1789-96.
7. Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 1996;4:77-84.
8. Studer RK, Georgescu HI, Miller LA, Evans CH. Inhibition of transforming growth factor β production by nitric oxide-treated chondrocytes: implications for matrix synthesis. Arthritis Rheum 1999;42:248-57.
9. Stefanovic-Racic M, Morales TI, Taskiran D, McIntyre LA, Evans CH. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures. J Imniunol 1996;156:1213-20.
10. Oh M, Fukuda K, Asada S, Yasuda Y, Tanaka S. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: involvement of peroxynitrite. J Rheumatol 1998;25:2169-74.
11. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
12. Blanco FJ, Lotz M. IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 1995;218:319-25.
13. Clancy RM, Abramson SB, Kohne C, Rediske J. Nitric oxide attenuates cellular hexose monophosphate shunt response to oxidants in articular chondrocytes and acts to promote oxidant injury. J Cell Physiol 1997;172:183-91.
14. Rediske J, Koehne C, Stoyanovsky S, Abramson S, Clancy B. TNFα sensitizes articular chondrocytes to oxidant stress [abstract]. Arthritis Rheum 1999;42 Suppl 9:S404.
15. Halverson PB, McCarty D. Basic calcium phosphate (apatite, octacalcium phosphate, tricalcium phosphate) crystal deposition diseases; calcinosis. In: Koopman W, editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams and Wilkins; 1997. p. 2127-46.
16. Ryan LM, McCarty DJ. Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: Koopman W, editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams and Wilkins; 1997. p. 2103-26.
17. Cheung HS, Ryan LM. Phosphocitrate blocks nitric oxide-induced calcification of cartilage and chondrocyte-derived apoptotic bodies. Ostreoarthritis Cartilage 1999;7:409-12.
18. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75-85.
19. Hashimoto S, Ochs RL, Rosce F, Quach J, McCabe G, Solan J, et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A 1998;95:3094-9.
20. Anderson HC. Molecular biology of matrix vesicles. Clin Orthop 1995;314:266-80.
21. Brookes PS, Bolanos JP, Heales SJ. The assumption that nitric oxide inhibits mitochondrial ATP synthesis is correct. FEBS Lett 1999;446:261-3.
22. Brown GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999;1411:351-69.
23. Koivisto A, Pittner J, Froelich M, Persson AE. Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide. Kidney Int 1999;55:2368-75.
24. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH. Nitric oxide and energy production in articular chondrocytes. J Cell Physiol 1994;159:274-80.
25. Johnson K, Vaingankar S, Chen Y, Moffa A, Goldring MB, Sano K, et al. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum 1999;42:1986-97.
26. Tushan FS, Rodnan GP, Altman M, Robin ED. Anaerobic glycolysis and lactate dehydrogenase (LDH) isozymes in articular cartilage. J Lab Clin Med 1969;73:649-50.
27. Lee RB, Urban JP. Evidence for a negative Pasteur effect in articular cartilage. Biochem J 1997;321:95-102.
28. Marcus RE, Srivastava VML. Effect of low oxygen tension on glucose-metabolizing enzymes in cultured articular chondrocytes. Soc Exp Biol Med Proc 1973;143:488-91.
29. Oegema TR Jr, Thompson RC. Metabolism of chondrocytes derived from normal and osteoarthritic human cartilage. In: Kuettner K, editor. Articular cartilage biochemistry. New York: Raven Press; 1986. p. 257-71.
30. Murphy AN, Fiskum G, Beal MF. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab 1999;19:231-45.
31. Shapiro IM, Golub EE, Kakuta S, Hazelgrove J, Harvey J. Chance B. Initiation of endochondral calcification is related to changes in the redox state of hypertrophic chondrocytes. Science 1982;217: 950-2.
32. Matsumoto H, DeBolt K, Shapiro IM. Adenine, guanine, and inosine nucleotides of chock growth cartilage: relationship between energy status and the mineralization process. J Bone Miner Res 1988;3:347-52.
33. Johnson K, Moffa A, Pritzker K, Chen Y, Goding J, Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 (PC-1) regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 1999;14:883-92.
34. Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, Ikegawa S. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet 1998;19: 271-3.
35. Meyer JL. Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 1984;231:1-8.
36. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994;94:2307-16.
37. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309-12.
38. Petit PX, Zamzami N, Vayssiere JL, Mignotte B, Kroemer G, Castedo M. Implication of mitochondria in apoptosis. Mol Cell Biochem 1997;174:185-8.
39. Galitovsky VE, Gogvadze VG. Inhibitors of mitochondrial energy production prevent DNA internucleosomal fragmentation in thymocytes. Biochemistry 1998;63:1374-7.
40. Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 1998;102-103:139-42.
41. Leist M, Single B, Naumann H, Fava E, Simon B, Kuhnle S, et al. Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem Biophys Res Commun 1999;258: 215-21.
42. Singh RJ, Hogg N, Joseph J, Konorev E, Kalyanaraman B. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors. Arch Biochem Biophys 1999;361: 331-9.
43. Blanco FJ, Guitian R, Vázquez-Martul E, de Toro FJ, Galdo F. Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis Rheum 1998;41:284-9.
44. Moos V, Fickert S, Muller B, Weber U, Sieper J. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol 1999;26:870-9.
45. Ryan LM, Rachow JW, McCarty DJ. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J Rheumatol 1991;18:716-20.
46. Ishikawa K, Masuda I, Ohira T, Yokoyama M. A histological study of calcium pyrophosphate dihydrate crystal-deposition disease. J Bone Joint Surg Am 1989;71:875-86.
47. Rosenthal AK, Henry LA. Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes. J Rheumatol 1999;26: 395-401.
48. Kirsch T, Nah HD, Shapiro IM, Pacifici M. Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 1997;137:1149-60.
49. Brighton CT, Hunt RM. Mitochondrial calcium and its role in calcification. Clin Orthop 1974;100:406-16.
50. Derfus B, Kranendonk S, Camacho N, Mandel N, Kushnaryov V, Lynch K, et al. Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 1998;63:258-62.
51. Hauselmann HJ, Stefanovic-Racic M, Michel BA, Evans CH. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases. J Immunol 1998;160:1444-8.
52. Grishko VI, Druzhyna N, LeDoux SP, Wilson GL. Nitric oxide-induced damage to mtDNA and its subsequent repair. Nucleic Acids Res 1999;27:4510-6.
53. Papa S, Skulachev VP. Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997;174:305-19.